Last reviewed · How we verify

NCT03276390: HKTP

A Culturally Targeted Transplant Program

Completed NA Last updated 3 October 2022
What this trial tests

NA trial testing Hispanic Kidney Transplant Program (HKTP) in ESRD in 11,836 participants. Completed in 28 February 2021.

Timeline
18 January 2017
Primary endpoint
28 February 2021
28 February 2021

Quick facts

Lead sponsorNorthwestern University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment11,836
Start date18 January 2017
Primary completion28 February 2021
Estimated completion28 February 2021
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northwestern University

Who can join

Adults 18 to 100, any sex, with ESRD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter patient and graft survival, and worse quality of life. Cultural beliefs and linguistic barriers contribute to the disparity in LDKTs. The objective of the proposed study is to implement and evaluate Northwestern Medicine's® Hispanic Kidney Transplant Program, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial.
    Gordon EJ, Uriarte JJ, Lee J, Kang R, et al · · 2022 · cited 33× · PMID 34559944 · DOI 10.1111/ajt.16857
  2. A complex culturally targeted intervention to reduce Hispanic disparities in living kidney donor transplantation: an effectiveness-implementation hybrid study protocol.
    Gordon EJ, Lee J, Kang RH, Caicedo JC, et al · · 2018 · cited 33× · PMID 29769080 · DOI 10.1186/s12913-018-3151-5
  3. Implementing culturally competent transplant care and implications for reducing health disparities: A prospective qualitative study.
    Gordon EJ, Romo E, Amórtegui D, Rodas A, et al · · 2020 · cited 23× · PMID 33037746 · DOI 10.1111/hex.13124
  4. Disparities Persist Among Hispanic Patients: Completing Evaluation, Waitlisting, and Receiving a Kidney Transplant.
    Gordon EJ, Lee J, Kang R, Uriarte J, et al · · 2024 · cited 11× · PMID 38414978 · DOI 10.1097/txd.0000000000001595
  5. Financial Feasibility Analysis of a Culturally and Linguistically Competent Hispanic Kidney Transplant Program.
    Wang A, Caicedo JC, McNatt G, Abecassis M, et al · · 2021 · cited 10× · PMID 32282660 · DOI 10.1097/tp.0000000000003269
  6. Patients' perceptions of a culturally targeted Hispanic Kidney Transplant Program: A mixed methods study.
    Alhalel N, Francone NO, Salazar AM, Primeaux S, et al · · 2019 · cited 8× · PMID 31034642 · DOI 10.1111/ctr.13577
  7. Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program on Increasing Living Donation.
    Wang A, Caicedo JC, Mathur AK, Ruiz RM, et al · · 2023 · cited 7× · PMID 36346212 · DOI 10.1097/tp.0000000000004382
  8. Implementation and modification of an organizational-level intervention: a prospective analysis.
    Gordon EJ, Uriarte JJ, Anderson N, Romo E, et al · · 2022 · cited 6× · PMID 35659156 · DOI 10.1186/s43058-022-00296-0

Verify or expand the search:

Other recruiting trials for ESRD

Currently open trials in the same condition.

Other Northwestern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing